• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三尖瓣反流与死亡率升高相关,与肺压和右心衰竭无关:系统评价和荟萃分析。

Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis.

机构信息

Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.

Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

出版信息

Eur Heart J. 2019 Feb 1;40(5):476-484. doi: 10.1093/eurheartj/ehy641.

DOI:10.1093/eurheartj/ehy641
PMID:30351406
Abstract

AIMS

To undertake a systematic review and meta-analysis to determine the influence of tricuspid regurgitation (TR) severity on mortality.

METHODS AND RESULTS

We performed a systematic search for studies reporting clinical outcomes of patients with TR. The primary endpoint was all-cause mortality and secondary endpoints were cardiac mortality and hospitalization for heart failure (HF). Overall risk ratios (RR) and 95% confidence intervals (CIs) were derived for each endpoint according to the severity of TR by meta-analysing the effect estimates of eligible studies. Seventy studies totalling 32 601 patients were included in the analysis, with a mean (±SD) follow-up of 3.2 ± 2.1 years. Moderate/severe TR was associated with a two-fold increased mortality risk compared to no/mild TR (RR 1.95, 95% CI 1.75-2.17). Moderate/severe TR remained associated with higher all-cause mortality among 13 studies which adjusted for systolic pulmonary arterial pressures (RR 1.85, 95% CI 1.44-2.39), and 15 studies, which adjusted for right ventricular (RV) dysfunction (RR 1.78, 95% CI 1.49-2.13). Moderate/severe TR was also associated with increased cardiac mortality (RR 2.56, 95% CI 1.84-3.55) and HF hospitalization (RR 1.73, 95% CI 1.14-2.62). Compared to patients with no TR, patients with mild, moderate, and severe TR had a progressively increased risk of all-cause mortality (RR 1.25, 1.61, and 3.44, respectively; P < 0.001 for trend).

CONCLUSIONS

Moderate/severe TR is associated with an increased mortality risk, which appears to be independent of pulmonary pressures and RV dysfunction.

摘要

目的

进行系统评价和荟萃分析,以确定三尖瓣反流(TR)严重程度对死亡率的影响。

方法和结果

我们对报告 TR 患者临床结局的研究进行了系统检索。主要终点是全因死亡率,次要终点是心脏死亡率和心力衰竭(HF)住院率。根据 TR 严重程度对符合条件的研究的效应估计值进行荟萃分析,得出每个终点的总体风险比(RR)和 95%置信区间(CI)。共纳入 70 项研究,总计 32601 例患者,平均(±SD)随访 3.2±2.1 年。与无/轻度 TR 相比,中度/重度 TR 患者的死亡率风险增加了一倍(RR 1.95,95%CI 1.75-2.17)。在调整了收缩压肺动脉压(RR 1.85,95%CI 1.44-2.39)的 13 项研究和调整了右心室(RV)功能障碍(RR 1.78,95%CI 1.49-2.13)的 15 项研究中,中度/重度 TR 仍与较高的全因死亡率相关。中度/重度 TR 还与增加的心脏死亡率(RR 2.56,95%CI 1.84-3.55)和 HF 住院率(RR 1.73,95%CI 1.14-2.62)相关。与无 TR 的患者相比,轻度、中度和重度 TR 的患者全因死亡率的风险逐渐增加(RR 分别为 1.25、1.61 和 3.44;P<0.001 趋势)。

结论

中度/重度 TR 与死亡率增加相关,且似乎独立于肺动脉压和 RV 功能障碍。

相似文献

1
Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis.三尖瓣反流与死亡率升高相关,与肺压和右心衰竭无关:系统评价和荟萃分析。
Eur Heart J. 2019 Feb 1;40(5):476-484. doi: 10.1093/eurheartj/ehy641.
2
Comparison of Survival in Patients With Clinically Significant Tricuspid Regurgitation With and Without Heart Failure (From the Optum Integrated File).有和没有心力衰竭的具有临床显著意义三尖瓣反流患者的生存情况比较(来自Optum综合档案)
Am J Cardiol. 2021 Apr 1;144:125-130. doi: 10.1016/j.amjcard.2020.12.070. Epub 2020 Dec 30.
3
Tricuspid regurgitation in acute heart failure: is there any incremental risk?三尖瓣反流在急性心力衰竭中的作用:是否存在额外风险?
Eur Heart J Cardiovasc Imaging. 2018 Sep 1;19(9):993-1001. doi: 10.1093/ehjci/jex343.
4
Effect of tricuspid regurgitation and the right heart on survival after transcatheter aortic valve replacement: insights from the Placement of Aortic Transcatheter Valves II inoperable cohort.三尖瓣反流及右心对经导管主动脉瓣置换术后生存的影响:来自主动脉经导管瓣膜置入术II不可手术队列的见解
Circ Cardiovasc Interv. 2015 Apr;8(4). doi: 10.1161/CIRCINTERVENTIONS.114.002073.
5
Association of Tricuspid Regurgitation With Outcome in Acute Heart Failure.三尖瓣反流与急性心力衰竭结局的关系。
Circ Cardiovasc Imaging. 2023 Jul;16(7):566-576. doi: 10.1161/CIRCIMAGING.122.014988. Epub 2023 Jun 29.
6
Prevalence and impact of preoperative moderate/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement.术前中重度三尖瓣反流对接受经导管主动脉瓣置换术患者的患病率及影响
Catheter Cardiovasc Interv. 2015 Mar;85(4):677-84. doi: 10.1002/ccd.25512. Epub 2014 Apr 30.
7
Impact of tricuspid regurgitation on long-term survival.三尖瓣反流对长期生存的影响。
J Am Coll Cardiol. 2004 Feb 4;43(3):405-9. doi: 10.1016/j.jacc.2003.09.036.
8
Tricuspid Regurgitation Is Associated With Increased Risk of Mortality in Patients With Low-Flow Low-Gradient Aortic Stenosis and Reduced Ejection Fraction: Results of the Multicenter TOPAS Study (True or Pseudo-Severe Aortic Stenosis).三尖瓣反流与射血分数降低的低流量低梯度主动脉瓣狭窄患者死亡率增加相关:多中心 TOPAS 研究(真性或假性重度主动脉瓣狭窄)的结果。
JACC Cardiovasc Interv. 2015 Apr 20;8(4):588-96. doi: 10.1016/j.jcin.2014.08.019. Epub 2015 Mar 26.
9
Right ventricular dysfunction and tricuspid regurgitation in functional mitral regurgitation.功能性二尖瓣反流中的右心室功能障碍和三尖瓣反流。
ESC Heart Fail. 2021 Dec;8(6):4988-4996. doi: 10.1002/ehf2.13558. Epub 2021 Sep 22.
10
Prognostic Value of Pulmonary Hypertension, Right Ventricular Function and Tricuspid Regurgitation on Mortality After Transcatheter Mitral Valve Repair: A Systematic Review and Meta-Analysis.经导管二尖瓣修复术后肺动脉高压、右心室功能和三尖瓣反流对死亡率的预后价值:系统评价和荟萃分析。
Heart Lung Circ. 2022 May;31(5):696-704. doi: 10.1016/j.hlc.2021.11.017. Epub 2022 Jan 17.

引用本文的文献

1
The effect of chronic kidney disease on the association of tricuspid regurgitation with overall survival : Insights from SHEBAHEART big data.慢性肾脏病对三尖瓣反流与总生存率之间关联的影响:来自舍巴心脏大数据的见解
J Nephrol. 2025 Sep 15. doi: 10.1007/s40620-025-02377-4.
2
Cardiac Implantable Electronic Devices and Transcatheter Tricuspid Valve Replacement With the EVOQUE System: A Case-Review Series Highlighting Procedural and Management Considerations.心脏植入式电子设备与使用EVOQUE系统的经导管三尖瓣置换术:一个强调手术及管理注意事项的病例回顾系列
Struct Heart. 2025 Jul 26;9(9):100707. doi: 10.1016/j.shj.2025.100707. eCollection 2025 Sep.
3
[Interdisciplinary management of tricuspid valve regurgitation].
[三尖瓣反流的多学科管理]
Herz. 2025 Aug 28. doi: 10.1007/s00059-025-05329-7.
4
Percutaneous interventions in tricuspid valve disease: a new era in cardiac treatment.经皮三尖瓣疾病介入治疗:心脏治疗的新时代。
Ann Med Surg (Lond). 2025 May 30;87(7):4262-4280. doi: 10.1097/MS9.0000000000003437. eCollection 2025 Jul.
5
Right-sided heart failure in acute respiratory distress syndrome.急性呼吸窘迫综合征中的右心衰竭
Eur Respir Rev. 2025 Aug 20;34(177). doi: 10.1183/16000617.0060-2025. Print 2025 Jul.
6
Cardiac implantable electronic devices in the setting of tricuspid valve intervention: Risks, options, extraction and future perspectives: A state-of-the-art review.三尖瓣介入治疗中的心脏植入式电子设备:风险、选择、取出及未来展望:一篇最新综述
Heart Rhythm O2. 2025 Feb 28;6(6):880-892. doi: 10.1016/j.hroo.2025.02.016. eCollection 2025 Jun.
7
Association between psoas muscle area and outcomes after transcatheter tricuspid valve repair.经导管三尖瓣修复术后腰大肌面积与预后的关系。
Cardiovasc Interv Ther. 2025 May 27. doi: 10.1007/s12928-025-01136-3.
8
Quality of life after transcatheter tricuspid valve repair: results from the Tri.FR trial.经导管三尖瓣修复术后的生活质量:Tri.FR试验结果
ESC Heart Fail. 2025 Aug;12(4):3053-3061. doi: 10.1002/ehf2.15327. Epub 2025 May 19.
9
Right Ventricular-Pulmonary Artery Uncoupling and Strain in Acute Heart Failure.急性心力衰竭时的右心室-肺动脉解耦联与应变
J Am Heart Assoc. 2025 May 6;14(9):e039858. doi: 10.1161/JAHA.124.039858. Epub 2025 May 2.
10
Association between tricuspid regurgitation and heart failure outcomes: A meta-analysis.三尖瓣反流与心力衰竭结局之间的关联:一项荟萃分析。
ESC Heart Fail. 2025 Aug;12(4):2643-2651. doi: 10.1002/ehf2.15303. Epub 2025 Apr 17.